Home › MannKind Corporation, Danbury, Conn. Tuesday, January 26, 2016.
 

Keywords :   


MannKind Corporation, Danbury, Conn. Tuesday, January 26, 2016.

2016-04-05 23:31:44| Biotech - Topix.net

Shares of MannKind fell about 6 percent during trading Tuesday after the local pharmaceutical company announced it had regained the commercialization rights of its inhaled insulin, Afrezza. The commercialization of the drug had been handled in the past by Sanofi, a French pharmaceutical giant that told MannKind in January that it would no longer market the drug.

Tags: january tuesday corporation conn

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news
»
05.11PM responds to Sir Alan Bates after repeated requests
05.11American Angus elects 2024-25 board leaders
05.11Atlantic Tropical Weather Outlook
05.11Eastern North Pacific Tropical Weather Outlook
05.11Tropical Storm Rafael Graphics
05.11Tropical Storm Rafael Public Advisory Number 8A
05.11Summary for Tropical Storm Rafael (AT3/AL182024)
05.11Brazil gives green light to medicinal use of Cannabis in animals
More »